Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Parent and child perspectives on family interactions related to melanoma risk and prevention after CDKN2A/p16 testing of minor children.

Wu YP, Aspinwall LG, Parsons B, Stump TK, Nottingham K, Kohlmann W, Champine M, Cassidy P, Leachman SA.

J Community Genet. 2020 Jan 18. doi: 10.1007/s12687-020-00453-9. [Epub ahead of print]

PMID:
31955387
2.

Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice.

Grossman D, Kim CC, Hartman RI, Berry E, Nelson KC, Okwundu N, Curiel-Lewandrowski C, Leachman SA, Swetter SM.

Melanoma Manag. 2019 Dec 17;6(4):MMT32. doi: 10.2217/mmt-2019-0016. Review.

3.

A pilot study of a telehealth family-focused melanoma preventive intervention for children with a family history of melanoma.

Wu YP, Boucher K, Hu N, Hay J, Kohlmann W, Aspinwall LG, Bowen DJ, Parsons BG, Nagelhout ES, Grossman D, Mooney K, Leachman SA, Tercyak KP.

Psychooncology. 2020 Jan;29(1):148-155. doi: 10.1002/pon.5232. Epub 2019 Nov 10.

PMID:
31520429
4.

Use of new molecular tests for melanoma by pigmented-lesion experts.

Varedi A, Gardner LJ, Kim CC, Chu EY, Ming ME, Leachman SA, Curiel-Lewandrowski C, Swetter SM, Grossman D.

J Am Acad Dermatol. 2020 Jan;82(1):245-247. doi: 10.1016/j.jaad.2019.08.022. Epub 2019 Aug 13. No abstract available.

PMID:
31415835
5.

CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.

Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, Cassidy PB, Petrie T, Liley B, Leachman SA.

Genet Med. 2020 Jan;22(1):26-34. doi: 10.1038/s41436-019-0608-9. Epub 2019 Aug 2.

6.

Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting.

Leachman SA, Hornyak TJ, Barsh G, Bastian BC, Brash DE, Cleaver JE, Cooper CD, D'Orazio JA, Fujita M, Holmen SL, Indra AK, Kraemer KH, Le Poole IC, Lo RS, Lund AW, Manga P, Pavan WJ, Setaluri V, Stemwedel CE, Kulesz-Martin MF.

J Invest Dermatol. 2020 Feb;140(2):269-274. doi: 10.1016/j.jid.2019.03.1164. Epub 2019 Jul 23. No abstract available.

PMID:
31348921
7.

A four-group experiment to improve Western high school students' sun protection behaviors.

Wu YP, Parsons BG, Nagelhout E, Haaland B, Jensen J, Zaugg K, Caputo H, Lensink R, Harding G, Yancey J, Klein SZ, Leachman SA, Tercyak KP.

Transl Behav Med. 2019 May 16;9(3):468-479. doi: 10.1093/tbm/ibz021.

PMID:
31094440
8.

MoleMapper: an application for crowdsourcing mole images to advance melanoma early-detection research.

Petrie T, Samatham R, Goodyear SM, Webster DE, Leachman SA.

Semin Cutan Med Surg. 2019 Mar 1;38(1):E49-E56. doi: 10.12788/j.sder.2019.001. Review.

PMID:
31051024
9.

Parent and child perspectives on perceived barriers to child sun protection and their association with sun protection strategies among children of melanoma survivors.

Wu YP, Parsons BG, Aspinwall LG, Hay JL, Boucher KM, Caputo H, Mooney R, Grossman D, Leachman SA.

Pediatr Dermatol. 2019 May;36(3):317-323. doi: 10.1111/pde.13796. Epub 2019 Mar 20.

PMID:
30895676
10.

Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.

Parsons BG, Hay JL, Aspinwall LG, Zaugg K, Zhu A, Mooney RH, Klein SZ, Grossman D, Leachman SA, Wu YP.

J Cancer Educ. 2019 Feb 15. doi: 10.1007/s13187-019-01489-3. [Epub ahead of print]

PMID:
30771212
11.

Reply to Reimann et al.

Clarke LE, Leachman SA.

Mod Pathol. 2019 May;32(5):725-727. doi: 10.1038/s41379-018-0197-1. Epub 2019 Jan 21. No abstract available.

12.

Melanoma Early Detection: Big Data, Bigger Picture.

Petrie T, Samatham R, Witkowski AM, Esteva A, Leachman SA.

J Invest Dermatol. 2019 Jan;139(1):25-30. doi: 10.1016/j.jid.2018.06.187. Epub 2018 Oct 25. Review.

13.

Frontiers in pigment cell and melanoma research.

Filipp FV, Birlea S, Bosenberg MW, Brash D, Cassidy PB, Chen S, D'Orazio JA, Fujita M, Goh BK, Herlyn M, Indra AK, Larue L, Leachman SA, Le Poole C, Liu-Smith F, Manga P, Montoliu L, Norris DA, Shellman Y, Smalley KSM, Spritz RA, Sturm RA, Swetter SM, Terzian T, Wakamatsu K, Weber JS, Box NF.

Pigment Cell Melanoma Res. 2018 Nov;31(6):728-735. doi: 10.1111/pcmr.12728. Epub 2018 Oct 3.

14.

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Review. Erratum in: Cancer. 2019 Aug 1;125(15):2706.

15.

Mineral sunscreens not recommended by Consumer Reports: Suggestions to improve the review process.

Varedi A, Wu YP, Klein SZ, Leachman SA, Grossman D.

J Am Acad Dermatol. 2019 Mar;80(3):832-833. doi: 10.1016/j.jaad.2018.09.009. Epub 2018 Sep 18. No abstract available.

PMID:
30240772
16.

Daily Minutes of Unprotected Sun Exposure (MUSE) Inventory: Measure description and comparisons to UVR sensor and sun protection survey data.

Stump TK, Aspinwall LG, Gray EL, Xu S, Maganti N, Leachman SA, Alshurafa N, Robinson JK.

Prev Med Rep. 2018 Jul 24;11:305-311. doi: 10.1016/j.pmedr.2018.07.010. eCollection 2018 Sep.

17.

Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi.

Tahata S, Singh SV, Lin Y, Hahm ER, Beumer JH, Christner SM, Rao UN, Sander C, Tarhini AA, Tawbi H, Ferris LK, Wilson M, Rose A, Dietz CM, Hughes E, Fahey JW, Leachman SA, Cassidy PB, Butterfield LH, Zarour HM, Kirkwood JM.

Cancer Prev Res (Phila). 2018 Jul;11(7):429-438. doi: 10.1158/1940-6207.CAPR-17-0268. Epub 2018 Apr 24.

18.

Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children.

Wu YP, Parsons BG, Mooney R, Aspinwall LG, Cloyes K, Hay JL, Kohlmann W, Grossman D, Leachman SA.

J Community Health. 2018 Oct;43(5):993-1001. doi: 10.1007/s10900-018-0516-y.

19.

Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.

Tolar J, Bauer JW, Kaplan DH, Leachman SA, McGrath JA, Paller AS, Griffith-Bauer KA, Stemwedel CE, Kulesz-Martin MF.

J Invest Dermatol. 2018 Jun;138(6):1243-1248. doi: 10.1016/j.jid.2018.02.039. Epub 2018 May 2. No abstract available.

20.

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman SA.

Transl Behav Med. 2018 Jan 29;8(1):29-43. doi: 10.1093/tbm/ibx011.

21.

Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.

Stump TK, Aspinwall LG, Kohlmann W, Champine M, Hauglid J, Wu YP, Scott E, Cassidy P, Leachman SA.

J Genet Couns. 2018 Aug;27(4):955-967. doi: 10.1007/s10897-017-0185-5. Epub 2018 Jan 19.

22.

Management strategies of academic pigmented lesion clinic directors in the United States.

Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM, Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME.

J Am Acad Dermatol. 2018 Aug;79(2):367-369. doi: 10.1016/j.jaad.2017.12.069. Epub 2018 Jan 4. No abstract available.

PMID:
29307637
23.

Melanoma risk assessment based on relatives' age at diagnosis.

Wu YP, Kohlmann W, Curtin K, Yu Z, Hanson HA, Hashibe M, Parsons BG, Wong J, Schiffman JD, Grossman D, Leachman SA.

Cancer Causes Control. 2018 Feb;29(2):193-199. doi: 10.1007/s10552-017-0994-8. Epub 2017 Dec 14.

24.

A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma.

Wu YP, Nagelhout E, Aspinwall LG, Boucher KM, Parsons BG, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Leachman SA.

Patient Educ Couns. 2018 Mar;101(3):452-459. doi: 10.1016/j.pec.2017.10.008. Epub 2017 Oct 19.

25.

Integrating Skin Cancer-Related Technologies into Clinical Practice.

Winkelmann RR, Farberg AS, Glazer AM, Cockerell CJ, Sober AJ, Siegel DM, Leachman SA, High WA, Markowitz O, Berman B, Pariser DM, Goldenberg G, Rosen T, Rigel DS.

Dermatol Clin. 2017 Oct;35(4):565-576. doi: 10.1016/j.det.2017.06.018. Epub 2017 Aug 12. Review.

PMID:
28886814
26.

Assessing Genetic Expression Profiles in Melanoma Diagnosis.

Leachman SA, Mengden Koon S, Korcheva VB, White KP.

Dermatol Clin. 2017 Oct;35(4):537-544. doi: 10.1016/j.det.2017.06.016. Epub 2017 Aug 7. Review.

27.

SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.

Chen LL, Zhu J, Schumacher J, Wei C, Ramdas L, Prieto VG, Jimenez A, Velasco MA, Tripp SR, Andtbacka RHI, Gouw L, Rodgers GM, Zhang L, Chan BK, Cassidy PB, Benjamin RS, Leachman SA, Frazier ML.

PLoS One. 2017 Sep 7;12(9):e0184154. doi: 10.1371/journal.pone.0184154. eCollection 2017.

28.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Study Group.

J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

29.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK.

Melanoma Manag. 2017 Mar;4(1):13-37. doi: 10.2217/mmt-2016-0022. Epub 2017 Mar 1. Review.

30.

A Large Skin-colored Nodule on the Plantar Foot: A Quiz. Melanoma associated with germline BAP1 mutation.

Rojek NW, Korcheva V, Leachman SA.

Acta Derm Venereol. 2017 Nov 15;97(10):1265-1266. doi: 10.2340/00015555-2726. No abstract available.

31.

Identification, genetic testing, and management of hereditary melanoma.

Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P.

Cancer Metastasis Rev. 2017 Mar;36(1):77-90. doi: 10.1007/s10555-017-9661-5.

32.

The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit.

Webster DE, Suver C, Doerr M, Mounts E, Domenico L, Petrie T, Leachman SA, Trister AD, Bot BM.

Sci Data. 2017 Feb 14;4:170005. doi: 10.1038/sdata.2017.5.

33.

Cellular and ultrastructural characterization of the grey-morph phenotype in southern right whales (Eubalaena australis).

Eroh GD, Clayton FC, Florell SR, Cassidy PB, Chirife A, Marón CF, Valenzuela LO, Campbell MS, Seger J, Rowntree VJ, Leachman SA.

PLoS One. 2017 Feb 7;12(2):e0171449. doi: 10.1371/journal.pone.0171449. eCollection 2017.

34.

Medicine: The final frontier in cancer diagnosis.

Leachman SA, Merlino G.

Nature. 2017 Feb 2;542(7639):36-38. doi: 10.1038/nature21492. Epub 2017 Jan 25. No abstract available.

35.

A Phase II Randomized Placebo-Controlled Trial of Oral N-acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo.

Cassidy PB, Liu T, Florell SR, Honeggar M, Leachman SA, Boucher KM, Grossman D.

Cancer Prev Res (Phila). 2017 Jan;10(1):36-44. doi: 10.1158/1940-6207.CAPR-16-0162. Epub 2016 Dec 5.

36.

Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma.

Wu YP, Aspinwall LG, Nagelhout E, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Cassidy P, Leachman SA.

J Cancer Educ. 2018 Aug;33(4):774-781. doi: 10.1007/s13187-016-1144-9.

37.

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.

Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT.

Oncotarget. 2016 Sep 27;7(39):64390-64399. doi: 10.18632/oncotarget.10453.

38.

A systematic review of interventions to improve adherence to melanoma preventive behaviors for individuals at elevated risk.

Wu YP, Aspinwall LG, Conn BM, Stump T, Grahmann B, Leachman SA.

Prev Med. 2016 Jul;88:153-67. doi: 10.1016/j.ypmed.2016.04.010. Epub 2016 Apr 16. Review.

39.

The state of melanoma: challenges and opportunities.

Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA.

Pigment Cell Melanoma Res. 2016 Jul;29(4):404-16. doi: 10.1111/pcmr.12475. Epub 2016 Apr 17.

40.

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Perić B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Consortium.

J Invest Dermatol. 2016 May;136(5):1066-1069. doi: 10.1016/j.jid.2016.01.009. Epub 2016 Jan 28. No abstract available.

41.

Detection of Exosomal miRNAs in the Plasma of Melanoma Patients.

Pfeffer SR, Grossmann KF, Cassidy PB, Yang CH, Fan M, Kopelovich L, Leachman SA, Pfeffer LM.

J Clin Med. 2015 Dec 17;4(12):2012-27. doi: 10.3390/jcm4121957.

42.

Methods of Melanoma Detection.

Leachman SA, Cassidy PB, Chen SC, Curiel C, Geller A, Gareau D, Pellacani G, Grichnik JM, Malvehy J, North J, Jacques SL, Petrie T, Puig S, Swetter SM, Tofte S, Weinstock MA.

Cancer Treat Res. 2016;167:51-105. doi: 10.1007/978-3-319-22539-5_3. Review.

PMID:
26601859
43.

Beyond Red Hair and Sunburns: Uncovering the Molecular Mechanisms of MC1R Signaling and Repair of UV-Induced DNA Damage.

Cassidy PB, Abdel-Malek ZA, Leachman SA.

J Invest Dermatol. 2015 Dec;135(12):2918-2921. doi: 10.1038/jid.2015.349.

44.

Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer.

Lund AW, Medler TR, Leachman SA, Coussens LM.

Cancer Discov. 2016 Jan;6(1):22-35. doi: 10.1158/2159-8290.CD-15-0023. Epub 2015 Nov 9. Review.

45.

Reply to: "Nail curing UV lamps: Trivial exposure not cause for public alarm".

Curtis JA, Tanner P, Hull CM, Leachman SA.

J Am Acad Dermatol. 2015 Nov;73(5):e187. doi: 10.1016/j.jaad.2015.07.032. No abstract available.

PMID:
26475565
46.

The role of thioredoxin reductase 1 in melanoma metabolism and metastasis.

Cassidy PB, Honeggar M, Poerschke RL, White K, Florell SR, Andtbacka RH, Tross J, Anderson M, Leachman SA, Moos PJ.

Pigment Cell Melanoma Res. 2015 Nov;28(6):685-95. doi: 10.1111/pcmr.12398. Epub 2015 Aug 20.

PMID:
26184858
47.

Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Taber JM, Aspinwall LG, Stump TK, Kohlmann W, Champine M, Leachman SA.

J Behav Med. 2015 Oct;38(5):740-53. doi: 10.1007/s10865-015-9648-z. Epub 2015 Jul 16.

48.

Discussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing.

Wu YP, Aspinwall LG, Michaelis TC, Stump T, Kohlmann WG, Leachman SA.

J Community Genet. 2016 Jan;7(1):21-31. doi: 10.1007/s12687-015-0243-3. Epub 2015 Jun 23.

49.

Impact of melanoma genetic test reporting on perceived control over melanoma prevention.

Aspinwall LG, Stump TK, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

J Behav Med. 2015 Oct;38(5):754-65. doi: 10.1007/s10865-015-9631-8. Epub 2015 Mar 31.

50.

Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.

Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC.

JAMA Dermatol. 2015 Feb;151(2):212-8. doi: 10.1001/jamadermatol.2014.2694. Review.

PMID:
25409291

Supplemental Content

Loading ...
Support Center